Skip to main content
Year archive

Zelluna ASA — 2026 filings

All 39 regulatory filings released by Zelluna ASA (ULTI) in 2026, sourced directly from the official regulator.

39 Filings
2026 Period
2026 filings (39)
Filing Released Lang
Zelluna ASA: First Quarter 2026 results - Attachment: Zelluna-ASA-Q126-Presentation.pdf
Regulatory Filings
2026-05-07 Norwegian
Zelluna ASA: First Quarter 2026 results - Attachment: Zelluna-ASA-Q126-Report.pdf
Regulatory Filings
2026-05-07 Norwegian
Zelluna ASA: First Quarter 2026 results
Regulatory Filings
2026-05-07 Norwegian
Zelluna ASA: Første kvartal 2026
Regulatory Filings
2026-05-07 Norwegian
Zelluna ASA aktiverer det første kliniske senteret for ZIMA-101studien, og markerer dermed oppstart av klinisk gjennomføring
Regulatory Filings
2026-05-06 Norwegian
Zelluna ASA activates first clinical site for ZIMA-101, marking entry into clinical execution
Regulatory Filings
2026-05-06 Norwegian
Zelluna ASA: Invitation to First Quarter 2026 results webcast Presentation (corrected time)
Regulatory Filings
2026-05-04 English
Zelluna ASA - Annual General Meeting held on April 23, 2026 - Attachment: Minutes of the Annual General Meeting in Zelluna ASA 2026.pdf
AGM Information
2026-04-23 Norwegian
Zelluna ASA - Annual General Meeting held on April 23, 2026
Declaration of Voting Results & Voting Rights Announcements
2026-04-23 English
Zelluna ASA - Disclosure of voting rights of Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements
2026-04-08 English
Zelluna ASA - Mandatory notification of trade - Attachment: Zelluna ASA - PDMR.pdf
Director's Dealing
2026-03-27 English
Zelluna ASA - Mandatory notification of trade
Director's Dealing
2026-03-27 English
Zelluna to host Capital Markets Update 2026 - Attachment: Zelluna Capital Markets Update.pdf
Investor Presentation
2026-03-26 English
Zelluna to host Capital Markets Update 2026
Investor Presentation
2026-03-26 English
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 - Attachment: Appendix 5 - Recommendations by the Nomination Committee 2025.pdf
Proxy Solicitation & Information Statement
2026-03-26 English
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 - Attachment: Appendix 4 - Remuneration Report 2025.pdf
Remuneration Information
2026-03-26 English
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 - Attachment: Appendix 3 - Remuneration Guidelines 2026.pdf
Remuneration Information
2026-03-26 English
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 - Attachment: Appendix 2 - Annual Report 2025.pdf
Annual Report FY 2025
2026-03-26 English
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 - Attachment: Appendix 1 - Registration and proxy form to the Annual General Meeting.pdf
Proxy Solicitation & Information Statement
2026-03-26 Norwegian
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026 - Attachment: Zelluna ASA - Notice of Annual General Meeting 2026.pdf
Proxy Solicitation & Information Statement
2026-03-26 Norwegian
Zelluna ASA [ZLNA]: Notice of Annual General Meeting on 23 April 2026
AGM Information
2026-03-26 English
Zelluna ASA [ZLNA]: Annual Report 2025 - Attachment: 254900B4VALJZR9TL744-2025-12-31-1-en.zip
Annual Report (ESEF) FY 2025
2026-03-25 English
Zelluna ASA [ZLNA]: Annual Report 2025 - Attachment: Zelluna Annual Report 2025.pdf
Annual Report FY 2025
2026-03-25 English
Zelluna ASA [ZLNA]: Annual Report 2025
Report Publication Announcement
2026-03-25 English
Zelluna inngår samarbeid med Etcembly for AI-drevet TCR-utvikling
Regulatory Filings
2026-03-09 Norwegian
Zelluna announces collaboration with Etcembly for AI-enabled TCR engineering
Regulatory Filings
2026-03-09 English
Zelluna mottar UK MHRA og etisk godkjenning for oppstart av ZIMA-101 første-i-menneske klinisk studie
Regulatory Filings
2026-02-20 Norwegian
Zelluna Receives UK MHRA and Ethics Approval to Initiate ZIMA-101 First-in-Human Clinical Trial
Regulatory Filings
2026-02-20 English
Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering - Attachment: Zelluna-ASA-Q425-Presentation.pdf
Investor Presentation
2026-02-12 English
Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission - Attachment: Zelluna-ASA-Q425-Report.pdf
Interim / Quarterly Report Q4 2025
2026-02-12 English
Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering - Attachment: Zelluna-ASA-Q425-Report.pdf
Interim / Quarterly Report Q4 2025
2026-02-12 English
Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission - Attachment: Zelluna-ASA-Q425-Presentation.pdf
Investor Presentation
2026-02-12 English
Zelluna ASA: Fjerde kvartal 2025 - Viktig regulatorisk milepæl oppnådd med CTA-innlevering
Earnings Release Q4 2025
2026-02-12 Norwegian
Zelluna ASA: Fourth Quarter 2025 - Key regulatory milestone achieved with CTA Submission
Earnings Release Q4 2025
2026-02-12 English
Zelluna ASA - Grant of Share Options
Share Issue/Capital Change
2026-02-05 English
Zelluna ASA: Invitation to Fourth Quarter 2025 Results Webcast Presentation
Report Publication Announcement
2026-02-05 English
Zelluna utnevner Emilie Gauthy til Chief Technology Officer
Board/Management Information
2026-02-03 Norwegian
Zelluna promotes Emilie Gauthy to Chief Technology Officer
Board/Management Information
2026-02-03 English
Zelluna ASA: Approval and publication of prospectus
Capital/Financing Update
2026-01-15 English